[47]. Knockdown ofPFKFB2,CXCL14, orUCA1lead to the inhibition of acetyl-CoA Acetyltransferase-2, aglycolysis enzyme, suggesting that CAF-released CXCL14 mediates tumor development by affecting the UCA1/miR-182/PFKFB2 axis[47]. CXCL14, released from CAFs, inducesUCA1,and its interaction ...